Brief: Anthera Announces Positive Outcome Of Second Interim Futility Analysis In The Phase 3 Sollpura Study

Anthera Pharmaceuticals

22/01/2018 13:30

Jan 22 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O : 
    * ANTHERA ANNOUNCES POSITIVE OUTCOME OF SECOND INTERIM 
FUTILITY 
ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA: STUDY 
ON SCHEDULE FOR TOPLINE DATA THIS QUARTER 
    * ANTHERA PHARMACEUTICALS INC - ON TRACK TO REPORT TOPLINE 
DATA 
LATER THIS QUARTER FROM RESULT STUDY 
 
Source text for Eikon:  ID:nGNXOMMWMa  
Further company coverage:  ANTH.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))